WILLIAM MITCHELL, MD
Medical Practice in Nashville, TN

License number

Tennessee MD04424

Personal information

See more information about WILLIAM MITCHELL at radaris.com

Name

Address

Phone

William Mitchell, age 69

511 Hunting Hills Dr, Mount Juliet, TN 37122

(615) 758-8695

William Mitchell, age 68

5015 Jacksboro Pike Apt 8, Knoxville, TN 37918

William Mitchell

5023 Concord Rd, Gates, TN 38037

William Mitchell, age 68

5031 Stewarts Ferry Pike, Mount Juliet, TN 37122

(615) 415-4151

William Mitchell, age 89

5037 Joe Peay Rd, Spring Hill, TN 37174

(731) 445-5620

Organization information

See more information about WILLIAM MITCHELL at bizstanding.com

William Mitchell MD

4605 The Vanderbilt Clinic, Nashville, TN 37232

Phone:

(615) 322-0126 (Phone)

Description:

There are 32 doctors at this site. Surgery is not performed at this site.

William Marvin Mitchell

Professional information

See more information about WILLIAM MITCHELL at trustoria.com

Loan Officer

Specialties:

Purchase Loan, Refinancing, Home Equity, Mortgage Planning

Work:

First Choice Lending Services, LLC
51 Century Blvd #Suite# 111, Nashville 37214

Experience:

2 years

Links:

Site
Blog
LinkedIn

General Manager At Shelbyville Times-Gazette

Position:

General Manager at Shelbyville Times-Gazette

Location:

Greater Nashville Area

Industry:

Newspapers

Work:

Shelbyville Times-Gazette since Oct 2006 - General Manager The Fulton Leader May 1977 - Oct 2006 - Owner-Publisher

Education:

Murray State University 1972 - 1977
BS, Radio-TV

Skills:

Newspaper, Journalism, Social Media, Writing, Facebook, Printing Services, Graphic Design

Dr. William Mitchell, Nashville TN - MD (Doctor of Medicine)

Specialties:

Clinical Pathology

Address:

Vanderbilt Univ Med Ctr Pathlgy
4605 The Vanderbilt Clinic, Nashville 37232
(615) 322-0126 (Phone)

Certifications:

Clinical Pathology, 1974

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

Vanderbilt Univ Med Ctr Pathlgy
4605 The Vanderbilt Clinic, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232

Education:

Medical School
Vanderbilt University
Graduated: 1960
The Johns Hopkins Hospital
Vanderbilt Hosp
Intl Union Against Cancer

William Marvin Mitchell, Nashville TN

Specialties:

Pathology, Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine

Work:

Vumc
1161 21St Ave S, Nashville, TN 37232

Education:

Vanderbilt University (1960)

Diagnosis And Management Of Infection Caused By Chlamydia

US Patent:

6579854, Jun 17, 2003

Filed:

May 6, 1998

Appl. No.:

09/073661

Inventors:

William M. Mitchell - Nashville TN
Charles W. Stratton - Nashville TN

Assignee:

Vanderbilt University - Nashville TN

International Classification:

A61K 3170

US Classification:

514 31, 514152, 514192, 514198, 514311, 514601, 514631

Abstract:

The present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stages of the chlamydial life cycle is effective in substantially reducing infection. Products comprising combination of antichlamydial agents, novel compositions and pharmaceutical packs are also described.

Method Of Controlling Nephrotoxicity Of Anti-Tumor Plaintum Compounds

US Patent:

5002755, Mar 26, 1991

Filed:

Apr 24, 1989

Appl. No.:

7/344487

Inventors:

William M. Mitchell - Nashville TN
Mark M. Jones - Nashville TN
Mark A. Basinger - Nashville TN

Assignee:

Vanderbilt University - Nashville TN

International Classification:

A61K 4900, A61K 3324, A61K 3128

US Classification:

424 10

Abstract:

Nephrotoxicity of anti-tumor platinum coordination compounds (e. g. , cisplatin) is reduced by administering a dithiocarbamate chelator (e. g. , diethyldithiocarbamate) at least 12 hours before as well as immediately after the administration of the anti-tumor compound.

Diagnosis And Management Of Infection Caused By Chlamydia

US Patent:

6838552, Jan 4, 2005

Filed:

Nov 8, 2000

Appl. No.:

09/709201

Inventors:

William M. Mitchell - Nashville TN, US
Charles W. Stratton - Nashville TN, US

Assignee:

Vanderbilt University - Nashville TN

International Classification:

A61K 5100, A61K 39118, A61B 5055, G01N 3355, G01N 33567

US Classification:

5303895, 424 149, 424 934, 4242631, 435 71, 435 72, 435 732, 435 736, 435 78, 435 792, 435 793, 435 794, 435 795, 436512, 436532, 436535, 436545, 436546, 5303871, 5303879, 5303884

Abstract:

Methods And Reagents For The Treatment Of Multiple Sclerosis

US Patent:

7094397, Aug 22, 2006

Filed:

Feb 17, 2005

Appl. No.:

11/060088

Inventors:

Charles W. Stratton - Nashville TN, US
William M. Mitchell - Nashville TN, US
Subramaniam Sriram - Nashville TN, US

Assignee:

Vanderbilt Unversity - Nashville TN

International Classification:

A61K 38/21, A61K 31/7048, A61K 31/496, A61K 31/65, A61K 31/18

US Classification:

424 854, 514152, 514192, 51425213, 51425301, 514 28, 514291, 514312, 514602

Abstract:

The invention features methods and reagents for the diagnosis, monitoring, and treatment of multiple sclerosis. The invention is based in part on the discovery that is present in patients with multiple sclerosis, and that anti-chlamydial agents improve or sustain neurological function in these patients.

Diagnosis And Management Of Infection Caused By Chlamydia

US Patent:

6884784, Apr 26, 2005

Filed:

Mar 19, 2002

Appl. No.:

10/100759

Inventors:

William M. Mitchell - Nashville TN, US
Charles W. Stratton - Nashville TN, US

Assignee:

Vanderbilt University - Nashville TN

International Classification:

A61K031/70, A61K031/65, A61K031/43, A61K031/47, A61K031/18

US Classification:

514 31, 514152, 514192, 514198, 514311, 514601, 514631, 514824

Abstract:

The present invention provides a unique approach for the diagnosis and management of infections by species, particularly. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stages of the chlamydial life cycle is effective in substantially reducing infection. Products comprising combination of antichlamydial agents, novel compositions and pharmaceutical packs are also described.